Skip to main content
. 2022 Jan 7;12:105. doi: 10.1038/s41598-021-03706-w

Figure 1.

Figure 1

Cumulative rates of hepatocellular carcinoma (HCC) according to (A) soluble inducible T-cell co-stimulator (sICOS), (B) soluble programmed cell death-1 (sPD-1), (C) soluble CD40 (sCD40), and (D) soluble herpes virus entry mediator (sHVEM) levels at baseline.